Acta Chimica and Pharmaceutica Indica
ISSN: 2277-288X

Ovarian Cancer High Impact Factor Journals

New biomarkers that supplant or are utilized related to the ebb and flow ovarian malignant growth demonstrative antigen, CA125, are required for discovery of ovarian malignancy in the presurgical setting, just as for recognition of ailment repeat. We recently showed the upregulation of leucine-rich alpha-2-glycoprotein-1 (LRG1) in the sera of ovarian malignant growth patients contrasted with sound ladies utilizing quantitative mass spectrometry. LRG1 was measured by ELISA in serum from two generally huge companions of ladies with ovarian malignancy and kindhearted gynecological ailment. The outflow of LRG1 in ovarian disease tissues and cell lines was analyzed by quality microarray, turn around transcriptase polymerase chain response (RT-PCR), Western smear, immunocytochemistry and mass spectrometry. Mean serum LRG1 was higher in 58 ovarian disease patients than in 56 sound ladies (89.33 ± 77.90 versus 42.99 ± 9.88 ug/ml; p = 0.0008) and was most noteworthy among stage III/IV patients. 

High Impact List of Articles

Relevant Topics in Chemistry

Awards Nomination

Table of Contents

Google Scholar citation report
Citations : 968

Acta Chimica and Pharmaceutica Indica received 968 citations as per Google Scholar report

Citation image

Indexed In

  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Cosmos IF
  • Scientific Indexing Services (SIS)
  • ICMJE

View More

For Authors

For Librarians

Flyer

Open Access Journals